Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

6.960
+0.1902.81%
Volume:674.00K
Turnover:4.64M
Market Cap:5.67B
PE:-17.74
High:6.980
Open:6.890
Low:6.730
Close:6.770
52wk High:12.230
52wk Low:3.910
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:1.00
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.392
ROE:-7.76%
ROA:-5.07%
PB:1.37
PE(LYR):-17.74
PS:9.19

Loading ...

ASCLETIS-B (01672) Invests HKD 948,700 to Buy Back 100,000 Shares on October 15

Stock News
·
Oct 15, 2025

Zhongjiang Wanxi Pharmaceutical: Village-Enterprise Collaboration Activates Revitalization Momentum

Deep News
·
Oct 15, 2025

Telix Pharmaceuticals Reports 53% Year-over-Year Q3 Revenue Growth

Deep News
·
Oct 14, 2025

ASCLETIS-B (01672) Completes Pre-NDA Communication with NMPA for Denifanstat (ASC40) New Drug Application

Stock News
·
Oct 14, 2025

ASCLETIS-B (01672) Repurchased 100,000 Shares for Approximately HK$968,300 on October 13

Stock News
·
Oct 13, 2025

Wintao Communications (301139) Investor Compensation Case Filed, Hainan Poly Pharm (300630) Compensation Proceedings Continue

Deep News
·
Oct 13, 2025

ASCLETIS-B (01672) Repurchases 100,000 Shares for HK$982,400 on October 10

Stock News
·
Oct 10, 2025

Hong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider

Stock News
·
Oct 09, 2025

EU Advances Sovereign AI Development: Announces €1 Billion Plan to Strengthen AI Applications, Focusing on Healthcare and Pharmaceutical Industries

Stock News
·
Oct 08, 2025

Hong Kong Stock Alert | ASCLETIS-B (01672) Surges Over 7% Again as Company Plans Up to HK$300 Million Share Buyback Program with Multiple Catalysts Expected in Second Half

Stock News
·
Oct 08, 2025

Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 10% in Afternoon Trading as AI Pharmaceutical Business Model Shows Validation, Company Takes Forward-Looking Approach in AI Drug Development

Stock News
·
Oct 08, 2025

From Beta to Alpha: Domestic First Facial Complex Solution Injectable "Dongyan" Approved for Market, SIHUAN PHARM's (00460) Value Reassessment Journey from Pharmaceutical Giant to Platform Medical Aesthetics Enterprise

Stock News
·
Oct 06, 2025

ASCLETIS-B Repurchases 100,000 Shares for HK$1.0836 Million on October 3

Deep News
·
Oct 06, 2025

ASCLETIS-B (01672) Repurchases 100,000 Shares for HK$1.0836 Million on October 3

Stock News
·
Oct 03, 2025

Trump Administration Targets Pharmaceutical, AI, Energy, and Mining Sector Deals Ahead of Midterm Elections

Deep News
·
Oct 02, 2025

Ascletis-B (01672) Plans to Use Up to HK$300 Million for Share Repurchase

Stock News
·
Oct 02, 2025

European Stocks Surge Past March Record Highs as Pharmaceutical Sector Rallies

Deep News
·
Oct 02, 2025

Trump Praises Eli Lilly, Hints at More Pharmaceutical Agreements

Deep News
·
Oct 01, 2025

ASCLETIS-B (01672) Grants 650,000 Stock Options in Total

Stock News
·
Sep 30, 2025

IPO News | Betta Pharmaceuticals Co.,Ltd. (300558.SZ) Files Application with Hong Kong Stock Exchange, Successfully Transforms into "Platform-Type Pharmaceutical Enterprise"

Stock News
·
Sep 30, 2025